AU2003299311A1 - Treatment of neuro-psychiatric disorders - Google Patents

Treatment of neuro-psychiatric disorders

Info

Publication number
AU2003299311A1
AU2003299311A1 AU2003299311A AU2003299311A AU2003299311A1 AU 2003299311 A1 AU2003299311 A1 AU 2003299311A1 AU 2003299311 A AU2003299311 A AU 2003299311A AU 2003299311 A AU2003299311 A AU 2003299311A AU 2003299311 A1 AU2003299311 A1 AU 2003299311A1
Authority
AU
Australia
Prior art keywords
neuro
treatment
psychiatric disorders
psychiatric
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003299311A
Inventor
Dominique De Quervain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Zuerich
Original Assignee
Universitaet Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Zuerich filed Critical Universitaet Zuerich
Publication of AU2003299311A1 publication Critical patent/AU2003299311A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AU2003299311A 2002-12-18 2003-12-15 Treatment of neuro-psychiatric disorders Abandoned AU2003299311A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43476802P 2002-12-18 2002-12-18
US60/434,768 2002-12-18
PCT/EP2003/014247 WO2004054587A1 (en) 2002-12-18 2003-12-15 Treatment of neuro-psychiatric disorders

Publications (1)

Publication Number Publication Date
AU2003299311A1 true AU2003299311A1 (en) 2004-07-09

Family

ID=32595304

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003299311A Abandoned AU2003299311A1 (en) 2002-12-18 2003-12-15 Treatment of neuro-psychiatric disorders

Country Status (2)

Country Link
AU (1) AU2003299311A1 (en)
WO (1) WO2004054587A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999017779A1 (en) * 1997-10-06 1999-04-15 The Board Of Trustees Of Leland Stanford Jr. University Methods for treating psychosis associated with glucocorticoid related dysfunction
WO2001026642A2 (en) * 1999-10-08 2001-04-19 Joyce Corinne Bechthold Methods and compositions for treating neurobehavioral disorders
EP1201660B1 (en) * 2000-10-30 2005-08-31 Pfizer Products Inc. Glucocorticoid receptor modulators

Also Published As

Publication number Publication date
WO2004054587A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
AU2003286567A1 (en) Methods for the treatment of skin disorders
AU2003258305A1 (en) Combination therapy for treatment of fibrotic disorders
AU2002257936A1 (en) Methods of well treatment
AU2003274342A1 (en) Compositions for the treatment of autoimmune disorders
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2003283257A1 (en) Scalp treatment
AU2003286728A1 (en) Compounds for the treatment of metabolic disorders
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
AU2003293099A1 (en) Treatment of dna damage related disorders
GB0213869D0 (en) The treatment of pain
AU2003260778A1 (en) Treatment of pipes
AU2003282722A1 (en) Therapeutic compositions
AU2003268923A1 (en) Treatment of aml
AU2002952086A0 (en) Treatment of osteoarthritis
AU2003219580A1 (en) Novel therapeutical use of byakangelicin
AU2002952129A0 (en) Treatment of hypersensitivity conditions
AU2003270615A1 (en) Treatment of steatosis using hyperthermia
AU2003274885A1 (en) Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
AU2003207315A1 (en) Treatment of muscle damage
GB0201025D0 (en) The treatment of degenerative diseases
GB0217493D0 (en) Novel methods of treatment
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2003250329A1 (en) Regulation of novel human asparagine-hydroxylases
AU2003299311A1 (en) Treatment of neuro-psychiatric disorders
AU2003274359A1 (en) Treatment of fluids

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase